Bifulco M - Search Results

1

What we know and do not know about the cannabinoid receptor 2 (CB2).

Malfitano AM, Basu S, Maresz K, Bifulco M, Dittel BN. Malfitano AM, et al. Among authors: bifulco m. Semin Immunol. 2014 Oct;26(5):369-79. doi: 10.1016/j.smim.2014.04.002. Epub 2014 May 28. Semin Immunol. 2014. PMID: 24877594 Free PMC article. Review.

2

Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis.

Malfitano AM, Matarese G, Pisanti S, Grimaldi C, Laezza C, Bisogno T, Di Marzo V, Lechler RI, Bifulco M. Malfitano AM, et al. Among authors: bifulco m. J Neuroimmunol. 2006 Feb;171(1-2):110-9. doi: 10.1016/j.jneuroim.2005.09.005. Epub 2005 Oct 18. J Neuroimmunol. 2006. PMID: 16239036

3

Anandamide inhibits adhesion and migration of breast cancer cells.

Grimaldi C, Pisanti S, Laezza C, Malfitano AM, Santoro A, Vitale M, Caruso MG, Notarnicola M, Iacuzzo I, Portella G, Di Marzo V, Bifulco M. Grimaldi C, et al. Among authors: bifulco m. Exp Cell Res. 2006 Feb 15;312(4):363-73. doi: 10.1016/j.yexcr.2005.10.024. Epub 2005 Dec 15. Exp Cell Res. 2006. PMID: 16343481

4

From cannabis to endocannabinoids in multiple sclerosis: a paradigm of central nervous system autoimmune diseases.

Malfitano AM, Matarese G, Bifulco M. Malfitano AM, et al. Among authors: bifulco m. Curr Drug Targets CNS Neurol Disord. 2005 Dec;4(6):667-75. doi: 10.2174/156800705774933087. Curr Drug Targets CNS Neurol Disord. 2005. PMID: 16375684 Review.

5

Helicobacter pylori has stimulatory effects on naive T cells.

Malfitano AM, Cahill R, Mitchell P, Frankel G, Dougan G, Bifulco M, Lombardi G, Lechler RI, Bamford KB. Malfitano AM, et al. Among authors: bifulco m. Helicobacter. 2006 Feb;11(1):21-30. doi: 10.1111/j.0083-8703.2006.00374.x. Helicobacter. 2006. PMID: 16423086

6

The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism.

Sarnataro D, Pisanti S, Santoro A, Gazzerro P, Malfitano AM, Laezza C, Bifulco M. Sarnataro D, et al. Among authors: bifulco m. Mol Pharmacol. 2006 Oct;70(4):1298-306. doi: 10.1124/mol.106.025601. Epub 2006 Jul 5. Mol Pharmacol. 2006. PMID: 16822929

7

From anecdotal evidence of cannabinoids in multiple sclerosis to emerging new therapeutical approaches.

Bifulco M, Laezza C, Malfitano AM. Bifulco M, et al. Mult Scler. 2007 Jan;13(1):133-4. doi: 10.1177/1352458506071303. Mult Scler. 2007. PMID: 17294623 No abstract available.

8

Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells.

Malfitano AM, Toruner GA, Gazzerro P, Laezza C, Husain S, Eletto D, Orlando P, De Petrocellis L, Terskiy A, Schwalb M, Vitale E, Bifulco M. Malfitano AM, et al. Among authors: bifulco m. Immunol Lett. 2007 Apr 15;109(2):145-54. doi: 10.1016/j.imlet.2007.02.004. Epub 2007 Mar 5. Immunol Lett. 2007. PMID: 17360047

9

The N-terminal domain of 2',3'-cyclic nucleotide 3'-phosphodiesterase harbors a GTP/ATP binding site.

Stingo S, Masullo M, Polverini E, Laezza C, Ruggiero I, Arcone R, Ruozi E, Dal Piaz F, Malfitano AM, D'Ursi AM, Bifulco M. Stingo S, et al. Among authors: bifulco m. Chem Biol Drug Des. 2007 Dec;70(6):502-10. doi: 10.1111/j.1747-0285.2007.00592.x. Epub 2007 Nov 6. Chem Biol Drug Des. 2007. PMID: 17986204

10

Structures and micelle locations of the nonlipidated and lipidated C-terminal membrane anchor of 2',3'-cyclic nucleotide-3'-phosphodiesterase.

Esposito C, Scrima M, Carotenuto A, Tedeschi A, Rovero P, D'Errico G, Malfitano AM, Bifulco M, D'Ursi AM. Esposito C, et al. Among authors: bifulco m. Biochemistry. 2008 Jan 8;47(1):308-19. doi: 10.1021/bi701474t. Epub 2007 Dec 13. Biochemistry. 2008. PMID: 18076147

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

271 results

Search Page